Canada Markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.8039+0.0039 (+0.49%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 22.38M
Enterprise Value 20.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.84
Price/Book (mrq)5.81
Enterprise Value/Revenue 5.39
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.95
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32.0000
52 Week Low 30.6470
50-Day Moving Average 30.9033
200-Day Moving Average 31.1578

Share Statistics

Avg Vol (3 month) 3132.6k
Avg Vol (10 day) 361.35k
Shares Outstanding 527.84M
Implied Shares Outstanding 6N/A
Float 821.21M
% Held by Insiders 111.38%
% Held by Institutions 124.26%
Shares Short (Jul 15, 2024) 4112.2k
Short Ratio (Jul 15, 2024) 40.78
Short % of Float (Jul 15, 2024) 40.42%
Short % of Shares Outstanding (Jul 15, 2024) 40.40%
Shares Short (prior month Jun 14, 2024) 4186.05k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Apr 01, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-209.55%

Management Effectiveness

Return on Assets (ttm)-128.49%
Return on Equity (ttm)-272.79%

Income Statement

Revenue (ttm)3.73M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)195.40%
Gross Profit (ttm)N/A
EBITDA -12.71M
Net Income Avi to Common (ttm)-12.8M
Diluted EPS (ttm)-0.5800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.43M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)121.9k
Total Debt/Equity (mrq)3.16
Current Ratio (mrq)3.06
Book Value Per Share (mrq)0.15

Cash Flow Statement

Operating Cash Flow (ttm)-11.83M
Levered Free Cash Flow (ttm)-7.44M